Operating Room Efficiency in Breast Cancer Surgery

Operating room efficiency has become a critical concern in breast cancer care, where rising case volumes, multidisciplinary coordination and increasing demand for breast conserving surgery put pressure on radiology and surgical schedules. The way a breast lesion is localized before surgery has a direct impact on both operative time and theater planning. This article explains the main efficiency drivers in breast cancer surgery, why localization choices matter, and how modern surgical marker navigation supports faster procedures and more flexible scheduling.

Why Operating Room Efficiency Matters in Breast Cancer Care

Breast cancer is one of the most commonly treated cancers in many hospitals, with breast conserving surgery now the standard of care for most early stage disease. As case volumes grow, even small per case improvements in operative time and scheduling translate into significant capacity and cost effects across the surgical program. More efficient use of theater time can also reduce patient waiting periods, support faster initiation of adjuvant therapy and improve overall pathway performance.

For a broader view of breast cancer surgical care, see How Sirius Medical Oncology Medical Devices Support Breast Cancer Care.

The Main Drivers of Operating Room Time in Breast Surgery

Operative duration in breast conserving surgery is influenced by several factors. Surgeon experience, tumor size and location, the use of oncoplastic techniques and the need for sentinel or targeted axillary procedures all contribute. One often underappreciated driver is the localization technique used to identify non palpable lesions, which affects both the preoperative pathway and intraoperative navigation.

Same Day Versus Pre Planned Localization

Traditional wire localization must be performed on the day of surgery, requiring tight coordination between radiology and the operating room. A delay in either department can cascade into theater slot disruptions and patient cancellations. Wireless localization methods allow the marker to be placed days or weeks ahead of surgery, decoupling radiology and surgical scheduling and giving each team more autonomy.

For an in depth comparison of wire and seed based approaches, see Seed Localization vs Wire Guided and Wire Guided Localization in Breast Surgery.

Intraoperative Navigation

The technology used to find the marker during surgery also influences operative time. Systems that provide real time directional and distance information allow the surgeon to navigate to the target without repositioning guesswork. Systems vulnerable to interference from electrocautery or hematoma can require workarounds that add minutes to each procedure.

Clinical Evidence on Surgical Marker Navigation and Operating Room Time

A comparative clinical study by Chinn and colleagues at Stanford University, published in Annals of Surgical Oncology in October 2025 (doi: 10.1245/s10434-025-18354-x), evaluated 90 consecutive non palpable breast lesion procedures performed with two different wireless localization technologies. The cohort included 45 procedures using the Pintuition® system and 45 procedures using an alternative non wire device, all performed by a single experienced fellowship trained breast surgeon at the same institution.

Median operative time with Pintuition® was 37 minutes compared with 50 minutes for the alternative approach, a 13 minute reduction or 21 percent shorter procedure time. The difference remained significant after multivariable adjustment for body mass index, surgical indication and marker depth, with an adjusted p value of 0.02. Oncologic outcomes were equivalent, with identical positive margin rates and re excision rates of 2.2 percent in each group. A detailed summary is available in the clinical one pager.

What 13 Minutes Per Case Means at Program Level

At the level of a single procedure, a 13 minute reduction may seem modest. Across a breast surgery program treating several hundred non palpable lesions per year, the cumulative time savings allow additional cases to be scheduled, reduce anesthesia exposure for patients and improve resource utilization across the broader surgical schedule.

Scheduling Flexibility and Pathway Optimization

Operating room efficiency is not only about per case duration but also about how reliably the schedule holds. A prospective study by Ceccato and colleagues, published in Scientific Reports in February 2025 (doi: 10.1038/s41598-025-88430-5), reported on the first 200 cases of magnetic surgical marker navigation across two French cancer centers. The study documented significant improvement in theater planning compared with wire guided localization, with the marker placed up to several weeks before surgery in roughly 39.5 percent of cases. There was no significant difference in re excision rate between cases marked just before surgery and those marked weeks ahead. A summary is available in the clinical one pager.

Operational Considerations for Hospitals

Hospital teams evaluating localization technologies for breast cancer surgery typically consider a combination of factors. Beyond clinical outcomes, the procurement and operational decision often weighs theater time per case, scheduling flexibility, radiology workload, training requirements, durability of the signal in clinical conditions such as hematoma or electrocautery use, and any radiation related logistics. Resources from organizations indexed by the American Cancer Society and other professional bodies provide patient facing context, while peer reviewed literature available through PubMed supports the clinical case for individual technologies.

Coordinating Radiology and Surgery

Improvements in operating room efficiency for breast cancer surgery depend on coordination across the entire care pathway, from the initial biopsy through marker placement to the operating room and pathology. Localization technologies that simplify scheduling, reduce the need for same day procedures and provide reliable intraoperative navigation can support smoother pathway operation for multidisciplinary teams. For an explanation of the planning phase, see Preoperative Localization Planning in Breast Conserving Surgery.

How Sirius Medical Supports Efficient Breast Cancer Surgery

Sirius Medical developed the Pintuition System® to support both precision and workflow efficiency in breast cancer surgery. The Pintuition Marker® is a non radioactive magnetic marker placed under standard image guidance, with flexible timing relative to surgery within the approved indication, allowing radiology and the operating room to schedule independently.

Intraoperatively, the Pintuition System® provides surgeons with real time distance and directional navigation, with signal performance designed to remain reliable in the presence of fluid or hematoma and unaffected by electrocautery during the procedure. Published evidence supports the contribution of these features to reduced operative time and predictable theater planning.

Interested in Improving Surgical Localization?

Learn how Pintuition® can support precision, workflow efficiency and predictable theater planning in breast cancer surgery. Request a demo or explore the clinical overview for more information.

Disclaimer

This article is intended for informational purposes only and should not be considered medical advice. Clinical decisions should always be made by qualified healthcare professionals based on individual patient needs and current guidelines.